Increased levels of kynurenic acid in brains of genetically dystonic hamsters

Developmental Brain Research

Volumn 92, Issue 1, 1996, Pages 111-116

  Richter, Angelika ^a   Löscher, Wolfgang ^a   Baran, Halina ^b   Gramer, Martina ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Dystonia; Excitatory amino acid system; Hamster; Kynurenic acid; Kynurenine; Movement disorder

Indexed keywords

GLUTAMATE RECEPTOR ANTAGONIST; KYNURENIC ACID;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; DYSTONIA; HAMSTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MUTANT; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0342592252     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-3806(96)00002-8     Document Type: Article

References (40)

1. Angelini, L., Rumi, V., Lamperti, E. and Nardocci, N., Transient paroxysmal dystonia in infancy, Neuropediatrics, 19 (1988) 171-174.
2. Baran, H. and Schwarcz, R., Regional differences in the ontogenetic pattern of kynurenine aminotransferase in the rat brain, Dev. Brain Res., 74 (1993) 283-286.
3. Beal, M.F., Matson, W.R., Swartz, K.J., Gamache, P.H. and Bird, E.D., Kynurenine pathways measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid, J. Neurochem., 55 (1990) 1327-1339.
4. Beal, M.F., Swartz, K.J. and Isacson, O., Developmental changes in brain kynurenic acid concentrations, Dev. Brain Res., 68 (1992) 136-139.
5. Carlsson, M. and Carlsson, A., Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease, Trends Neurosci., 13 (1990) 272-276.
6. Carpenedo, R., Chiarugi, A., Russi, P., Lombardi, G., Carla, V., Pellicciari, R., Mattoli, L. and Moroni, F., Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities, Neuroscience, 61 (1994) 237-244.
7. DeLong, M.R., Primate models of movements disorders of basal ganglia origin, Trends Neurosci., 13 (1990) 281-285.
8. Deonna, T.-W., Ziegler, A.-L. and Nielsen, J., Transient idiopathic dystonia in infancy, Neuropediatrics, 22 (1991) 220.
9. Fredow, G. and Löscher, W., Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia, Eur. J. Pharmacol., 192 (1991) 207-219.
10. Fukui, S., Schwarcz, R., Rapoport, S.I., Takada, Y. and Smith, Q.R., Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism, J. Neurochem., 56 (1991) 2007-2017.
11. Gramsbergen, J.B.P., Schmidt, W., Turski, W.A. and Schwarcz, R., Age-related changes in kynurenic acid production in rat brain, Brain Res., 588 (1992) 1-5.
12. Jauch, D., Urbanski, E.M., Guidetti, P., Bird, E.D., Vonsattel, J.-P.G., Whetsell, W.O. and Schwarcz, R., Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases, J. Neurol. Sci., 130 (1995) 39-47.
13. Löscher, W., Blanke, T., Richter, A. and Hoppen, H.-O., Gonadal sex hormones and dystonia: experimental studies in genetically dystonic hamsters, Movement Dis., 10 (1995) 92-102.
14. Löscher, W., Fassbender, C.P., Gram, L., Gramer, M., Hörstermann, D., Zahner, B. and Stefan, H., Determination of GABA and vigabatrin in human plasma by rapid and simple HPLC method: correlation between clinical response to vigabatrin and increase in plasma GABA, Epilepsy Res., 14 (1993) 245.
15. Löscher, W., Fisher Jr., J.E., Schmidt, D., Fredow, G., Hönack, D. and Iturrian, W.B., The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia?, Movement Dis., 4 (1989) 219-232.
16. Löscher, W. and Hörstermann, D., Abnormalities in amino acid neurotransmitters in discrete brain regions of genetically dystonic hamsters, J. Neurochem., 59 (1992) 689-694.
17. Löscher, W. and Richter, A., The glycine/NMDA receptor ligand (+)-HA-966 but not D-cycloserine exert antidystonic efficacy in a genetic animal model of dystonia, Eur. J. Pharmacol., 239 (1993) 245-247.
18. Lou, G.L., Pinsky, C. and Sitar, D.S., Kynurenic acid distribution into brain and peripheral tissues of mice, Can. J. Physiol. Pharmacol., 72 (1994) 161-167.
19. McDonald, J.W. and Johnston, M.V., Physiological and pathophysiological roles of excitatory amino acids during central nervous system development, Brain Res. Rev., 15 (1990) 41-70.
20. McGeer, E.G. and McGeer, P.L., The dystonias, Canad. J. Neurol. Sci., 15 (1988) 447-483.
21. Michaelis, R., Asenbauer, C., Buchwald-Saal, M., Haas, G. and Kräteloh-Mann, I., Transitory neurological findings in a population of risk infants, Early Hum. Dev., 34 (1993) 143-153.
22. Moroni, F., Russi, P., Carla, V., De Luca, G. and Politi, V., The regulation of brain kynurenic acid content: focus on indole-3-pyruvic acid. In R. Schwarcz, S.N. Young and R.R. Brown (Eds.), Kynurenine and Serotonin Pathways, Adv. Exp. Med. Biol., 294, Plenum Press, New York, 1991, pp. 299-308.
23. Moroni, F., Russi, P., Lombardi, G., Beni, M. and Carla, V., Presence of kynurenic acid in mammalian brain, J. Neurochem., 51 (1988) 177-179.
24. Mundinger, F. and Milios, E., Erfahrungen mit Memantine bei der Behandlung schwerer spastischer und extrapyramidaler Bewegungsstörungen in Kombination mit der stereotaktischen Operation, Nervenarzt, 56 (1985) 106-109.
25. A /benzodiazepine receptor-chloride ionophore complex in a genetic model of paroxysmal dystonia: a quantitative autoradiographic analysis, Neuroscience, 64 (1995) 229-239.
26. O'Brien, M.W., Oltmans, G.A. and Lorden, J.F., Decreased quisqualate-sensitive glutamate binding in the cerebellar cortex of the dystonic rat, Soc. Neurosci. Abstr., 16 (1990) 1191.
27. Ogawa, T., Matson, W.R., Beal, M.F., Myers, H.R., Bird, E.D., Milbury, P. and Saso, S., Kynurenine pathway abnormalities in Parkinson's disease, Neurology, 42 (1992) 1702-1706.
28. Pratt, G.D., Richter, A., Möhler, H. and Löscher, W., Regionally selective and age-dependent alterations in benzodiazepine receptor binding in genetically dystonic hamsters, J. Neurochem., 64 (1995) 2153-2158.
29. Richter, A., Fredow, G. and Löscher, W., Antidystonic effects of the NMDA receptor antagonists memantine, MK-801 and CGP 37849 in a hamster model of paroxysmal dystonia, Neurosci. Lett., 133 (1991) 57-60.
30. Richter, A. and Löscher, W., Alterations in pharmacological sensitivity of GABAergic but not dopaminergic and glutaminergic systems during ontogenesis in dystonic mutant hamsters, Eur. J. Pharmacol., 231 (1993) 111-119.
31. Richter, A., Löscher, W. and Löschmann, P.-A., The AMPA receptor antagonist NBQX exerts antidystonic effects in an animal model of idiopathic dystonia, Eur. J. Pharmacol., 231 (1993) 287-291.
32. Richter, A., Löschmann, P.-A. and Löscher, W., The novel antiepileptic drug, lamotrigine, exerts prodystonic effects in a mutant hamster model of generalized dystonia, Eur. J. Pharmacol., 264 (1994) 345-351.
33. Robertson, R.G., Farmery, S.M., Sambrook, M.A. and Crossman, A.R., Dyskinesias in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus, Brain Res., 476 (1989) 317-322.
34. Schwarcz, R., Metabolism and function of brain kynurenines, Biochem. Soc. Transm., 21 (1993) 77-82.
35. Schwarcz, R. and Du, F., Quinolinic acid and kynurenic acid in the mammalian brain. In R. Schwarcz, S.N. Young and R.R. Brown (Eds.), Kynurenine and Serotonin Pathways, Adv. Exp. Med. Biol., 294, Plenum Press, New York, 1991, pp. 185-200.
36. Shibata, K., Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography, J. Chromatogr., 430 (1988) 376.
37. Stone, T.W., Neuropharmacology of quinolinic and kynurenic acids, Pharmacol. Rev., 45 (1993) 309-379.
38. Turski, W.A., Gramsbergen, J.B.P., Traitler, H. and Schwarcz, R., Rat brain slices produces and liberate kynurenic acid upon exposure to L-kynurenine, J. Neurochem., 52 (1989) 1629-1636.
39. Wahnschaffe, U., Fredow, G., Heintz, P. and Löscher, W., Neuropathological studies in a mutant hamster model of paroxysmal dystonia, Movement Dis., 5 (1990) 286-293.
40. Wu, H.-Q., Baran, H., Ungerstedt, U. and Schwarcz, R., Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and vivo, Eur. J. Neurosci., 4 (1992) 1264-1270.